维普中文期刊产品整合服务
97篇 您的检索式:作者名="AFIFI A M"
    题名 作者 年代 出处 被引量
1Biochemical changes in phenols,flavonoids,tannins,vitamin E,β-carotene and antioxidant activity during soaking of three white sorghum varieties显示文摘Objective:To investigate the changes in total phenols,flavonoids,tannins,vitamin E, β-carotene and antioxidant activity during soaking of three white sorghum varieties.Methods: The changes in total phenols,total ilavonoids,tannins,phenolic acids compounds,flavonoid components,vitamin E,P-carotene and antioxidant activity during soaking of sorghum grains were determined.Results:Total phenols,total flavonoids,tannins,vitamin E,P-carotene and antioxidant activity in raw sorghum were ranged from 109.21 to 116.70,45.91 to 54.69,1.39 to 21.79 mg/100 g,1.74 to 5.25,0.54 to 1.19 mg/kg and 21.72%to 27.69%and 25.29%to 31.97%,respectively. The above measured compounds were significantly decreased after soaking.p-Hydroxybenzoic acid,vanillic acid,syringic acid and cinnamic acid represent the major phenolic acids in Dorado variety.While ferulic acid,p-coumaric acid,gallic acid and caffeic acid represent the major phenolic acids in Shandaweel-6.On the other hand,protocatechuic acid represents the major phenolic acids in Giza-15.Regarding flavonoids components,Dorado was the highest variety in kampferol and naringenin while Shandaweel-6 was the highest variety in luteolin, apigenin,hypersoid,quercelin and christen.Finally,Giza-15 was the highest variety in catechin. Phenolic acids,flavonoid compounds and antioxidant activities were decreased after soaking. Conclusions:Sorghum varieties have moderate quantities from total phenols,total flavonoids, tannins,phenolic acids compounds,flavonoid components,vitamin E,P-carotene and antioxidant activity which decreased after soaking.Abd El-Moneim MR Afify Hossam S El-Beltagi Samiha M Abd El-Salam Azza A Omran 2012Asian Pacific Journal of Tropical Biomedicine2012,2,3:7
2Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study显示文摘BACKGROUND Chronic liver disease,particularly cirrhosis,is associated with worse outcomes in patients infected with coronavirus disease 2019(COVID-19).AIM To assess outcomes of COVID-19 infection among patients with pre-existing hepatitis C with or without liver cirrhosis.METHODS This multicenter,retrospective cohort study included all cases of confirmed coinfection of severe acute respiratory syndrome coronavirus 2 and chronic hepatitis C with or without liver cirrhosis who were admitted to six hospitals(Al-Sahel Hospital,Al-Matareya Hospital,Al-Ahrar Hospital,Ahmed Maher Teaching Hospital,Al-Gomhoreya Hospital,and the National Hepatology and Tropical Medicine Research Institute)affiliated with the General Organization for Teaching Hospitals and Institutes in Egypt.Patients were recruited from May 1,2020,to July 31,2020.Demographic,laboratory,imaging features,and outcomes were collected.Multivariate regression analysis was performed to detect factors affecting mortality.RESULTS This retrospective cohort study included 125 patients with chronic hepatitis C and COVID-19 co-infection,of which 64(51.20%)had liver cirrhosis and 40(32.00%)died.Fever,cough,dyspnea,and fatigue were the most frequent symptoms in patients with liver cirrhosis.Cough,sore throat,fatigue,myalgia,and diarrhea were significantly more common in patients with liver cirrhosis than in noncirrhotic patients.There was no difference between patients with and without cirrhosis regarding comorbidities.Fifteen patients(23.40%)with liver cirrhosis presented with hepatic encephalopathy.Patients with liver cirrhosis were more likely than non-cirrhotic patients to have combined ground-glass opacities and consolidations in CT chest scans:28(43.75%)vs 4(6.55%),respectively(P value<0.001).These patients also were more likely to have severe COVID-19 infection,compared to patients without liver cirrhosis:29(45.31%)vs 11(18.04%),respectively(P value<0.003).Mortality was higher in patients with liver cirrhosis,compared to those with no cirrhosis:33(51.56%)vs 9(14.75%),respectively(P value<0.001).All patients in Child-Pugh class A recovered and were discharged.Cirrhotic mortality occurred among decompensated patients only.A multivariate regression analysis revealed the following independent factors affecting mortality:Male gender(OR 7.17,95%CI:2.19–23.51;P value=0.001),diabetes mellitus(OR 4.03,95%CI:1.49–10.91;P value=0.006),and liver cirrhosis(OR 1.103,95%CI:1.037–1.282;P value<0.0001).We found no differences in liver function,COVID-19 disease severity,or outcomes between patients who previously received direct-acting antiviral therapy(and achieved sustained virological response)and patients who did not receive this therapy.CONCLUSION Patients with liver cirrhosis are susceptible to higher severity and mortality if infected with COVID-19.Male gender,diabetes mellitus,and liver cirrhosis are independent factors associated with increased mortality risk.Shimaa Afify Basem Eysa Fatma Abdel Hamid Omnia M Abo-Elazm Mohamed A Edris Rabab Maher Ahmed Abdelhalim Muhammad Mostafa Abdel Ghaffar Dalia A Omran Hend Ibrahim Shousha 2021World Journal of Gastroenterology2021,27,42:2
3Laboratory-based surveillance of patients with bacterial meningitis in Egypt (1998 - 2004) 显示文摘Afifi S Wasfy M O Azab M A 2007Eur J Clin Microbiol Infect Dis2007,26,5:1
4Cucurbitacins of cucumis prophetarum and cucumis prophetarum显示文摘Afifi M S Ross S A Elsohly M A 1999J Chem Ecol1999,25,4:1
5A Risk Identification Procedure for Construction Contracts-A Case Study of Pow er Station Projects in Egypt显示文摘HASSANEIN A A G AFIFY H M F 2007Civil Engineering and Environmental Systems2007,24,1:1
6Investigation of DC conductivity and switching phenomenon of Se80Te20-xGex amorphous system显示文摘AFIFI M A HEGAB N A ATYIA H E 2008Journal of Alloys and Compounds2008,463,12:1
7Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors 显示文摘Afify A M Tare S Durbin - Johnson B Int J Biol Markers0,26,1:1
8The Effect ofAdditives on Zinc Deposited from Zinc Sulfate Solutions显示文摘Afifi S E Ebaid A R Hegazy M M 1992JOM1992,44,1:1
9Diabetic nephropathy as a cause of end-stage renal disease in Egypt:a six-year study 显示文摘Afifi A EI SM E1 Sharkawy M 2004East Mediterr Health J2004,10,45:1
10Association between type 2 diabetes mellitus and Helicobacter pylori infection显示文摘Bener A Micallef R Afifi M 2007Irr Jrk J Gastroenterol2007,18,4:1
11Four- corner fusion and scaphoid excision using headless compression screws for SLAC and SNAC wrist deformities显示文摘Richards A A Afifi A M Moneim M S 2011Tech Hand Up Extrem Surg2011,15,2:1
12Effect of the takeup velocity on the higher-order structure of the melt-electrospun PLLA/PDLA blend fibers显示文摘Yamamoto M Nishikawa G Afifi A M 2015Sen-I Gakkaishi2015,71,3:1
13Purification and general properties of pectin methyl eserase form curvularia inaequails NRRL 13884 in solid state culture using orange peels as an inducer 显示文摘Afifi A F Fawzi E M Fooaad M A 2002Acta Micorbiclogica Polonica2002,51,3:1
14Emergence of a novel genotype of avian infectious bronchitis virus in Egypt 显示文摘Abdel-Moneim A S Afifi M A EI-Kady M F 2012Arch ViroI2012,157,12:1
15Structure of meltelectrospun poly(L-lactic acid)/poly(D-lactic acid)blend fibers显示文摘Nishikawa G Yamamoto M Afifi A M 2013Sen-I Gakkaishi2013,69,6:1
16On the solution of Endolymph equation using fractional calculus显示文摘Elshehawey E F Elbary Afifi N A S El-Shahed M 2001Applied Mathematics and Computation2001,124,:1
17Demodex folliculorum causing pathological lesions in immunocompetent children显示文摘Morsy T A Fayad M E Morsy A T Afify E M 2000J Egypt Soc Parasitol2000,30,:1
18Association betweentype2 diabetes mellitus and helicobacter pylori infection显示文摘Bener A Micallef R Afifi M et a1 2007Turk J Gastroenterol2007,,18:1
19Reductive Leaching of Ilmenite Ore in Hydrochloric Acid for Preparation of Synthetic Rutile 显示文摘Mahmoud M H H Afifi A A I Ibrahim I A 2004Hydrometallurgy2004,73,12:1
20Association between type 2 diabetes mellitus and Helicobacter pylori infection 显示文摘Bener A Micallef R Afifi M 2007Turk J Gastroenterol2007,18,4:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费